ImmunoPrecise’s proprietary technologies and products are positioned on the leading edge of antibody development, innovating our industry as a single source provider of the full complement of antibody discovery platforms. As an investor in ImmunoPrecise Antibodies, you’re joining us at the forefront of new, exciting, and valuable advancements in next-generation antibody discovery.
Investor RelationsFor investor inquiries please contact: LifeSci Advisors John Mullaly email@example.com
Financial StatementsPlease find our financials on Sedar in English and Français.
Analyst CoverageDownload Industrielle Alliance Report Chelsea Stellick +1 (403) 705 4982 firstname.lastname@example.org
ImmunoPrecise NewsletterCheck out our most recent blog post:Understanding the Chain of Infection
Sign Up for
Enter your email to receive financial information by email.